New labcorp test report helps identify insect stings and improve therapy decisions to combat allergic reactions

Burlington, n.c.--(business wire)--nearly 10 million people in the united states have a history of systemic or anaphylactic reaction to insect stings, with the risk of a severe and potentially life-threatening allergic reaction. to help facilitate more effective venom therapy, labcorp (nyse: lh), a leading global life sciences company, has launched its unique labcorp clinical decision support (cds) interpretative test report for its stinging insect component-specific ige test that provides alle
LH Ratings Summary
LH Quant Ranking